Eli Lilly and Company (LLY) closed at $1,144.09 on October 6, 2026, registering a gain of just 0.01% over the prior 24-hour period. The move was essentially flat, offering little directional signal on its own.
Zooming out, the picture is more mixed. Shares are down 3.53% over the past seven days, reflecting a stretch of selling pressure that has weighed on the stock through the week. Over the past 30 days, however, the decline is more modest at 0.40%, suggesting the recent weekly dip represents a sharper but relatively contained pullback.
Eli Lilly's market capitalization stands at $1,018.69 billion, keeping the pharmaceutical giant among the largest publicly traded companies by that measure. The trillion-dollar valuation underscores the scale of investor stakes tied to the stock's near-term movements.
Trading in LLY continues to draw attention given its size and position in the pharmaceutical sector. The data shows a stock that has largely held its ground over the past month despite the more pronounced weekly slide.
